Tardugno Michael H 4

What Happened
Michael H. Tardugno, Executive Chairman of Imunon, received 4,089 shares as an award (Form 4 code A) at an acquisition price of $2.06 per share, valued at roughly $8,423. This was a stock grant—an acquisition/award rather than a market purchase or sale, so it is a compensation-related grant rather than an expressed buy/sell market signal.

Key Details

• Transaction date: 2026-06-05 — grant of 4,089 shares at $2.06 per share (total ≈ $8,423).
• Filing date: 2026-06-09 (filed within the typical two-business-day Form 4 window for a 6/5 transaction).
• Shares owned after transaction: Not specified in the filing.
• Footnotes in the filing: F1 — stock granted in lieu of cash for base salary; F2 — shares were rolled over from a 401(k) plan.
• Transaction code: A = Award/Grant (not a sale or open-market purchase).

Context
The filing indicates these shares were issued as compensation (stock in lieu of base salary) and involved a 401(k) rollover detail; such grants are routine executive compensation actions and do not, by themselves, indicate the insider’s private view of the company’s stock.